ArticleInternational ophthalmology2025
Analysis of progranulin concentration in corneal epithelium and tears as a possible biomarker in the clinical diagnosis and progression of keratoconus.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the expression of progranulin [PGRN] and various inflammatory markers in corneal epithelium and tears of keratoconus [KC] patients and compare them with those of a healthy population.
methodsKC patients were allocated to mild, moderate and severe study groups according to Amsler-Krumeich classification. Tear samples for ELISA analysis were collected using plastic capillary tubes from KC patients and healthy individuals. Corneal epithelial tissues were collected from patients who underwent manual epithelial debridement during the epi-off accelerated corneal collagen crosslinking procedure for immunofluorescence. The expression of PGRN, TGF-ß1, MMPs, connexin 43 and TIMP-1 were compared between KC study groups.
resultsThe mean tear PRGN levels of the mild [n = 4], moderate [n = 15] and severe [n = 3] KC and healthy [n = 13] groups were 45.94 ± 32.2, 36.63 ± 36.5, 0.52 ± 40.7 and 47.41 ± 47.3 pg/mL, respectively [p = 0.957, p = 0.774 and p = 0.091]. No significant difference was observed between KC study groups regarding tear PGRN levels [p > 0.05]. In immunofluorescence, ImageJ analysis showed that PGRN expression decreased as the KC stage increased. The decrease between KC study groups was found to be statistically significant [p < 0.01]. In contrast to PGRN, a statistically significant increase in TGF-ß1, MMP-1 and TIMP-1 expressions and in similar to PGRN, a statistically significant decrease in MMP-2, MMP-9 and connexin 43 expressions were observed as the KC stage increased.
conclusionIn this study, our findings revealed that PGRN may have a role in the etiopathogenesis of KC. Further studies are needed to support our result.
Indexed as
Identifiers
40185942What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.